FCGR2A and cancer: Recent studies have verified the polymorphism of the FcγR gene affecting the efficiency of antibody-mediated pathogen clearance, like HIV-1.[36] Regarding their application in cancer research, their ability to mediate ADCC, enhance phagocytosis, and modulate immune responses positions them as a critical focus in the field.